Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The final phase of polio eradication: new vaccines and complex choices.

Cochi SL, Linkins RW.

J Infect Dis. 2012 Jan 15;205(2):169-71. doi: 10.1093/infdis/jir727. Epub 2011 Dec 8. No abstract available.

PMID:
22158681
2.

Poliovirus vaccines.

Racaniello VR.

Biotechnology. 1992;20:205-22. Review. No abstract available.

PMID:
1318134
3.

[Possible method of eradication of poliomyelitis as an infection].

Seĭbil' VB, Malyshkina LP.

Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun;(3):107-13. Review. Russian.

PMID:
22830285
4.

Control of poliomyelitis: a continuing paradox.

Horstmann DM.

J Infect Dis. 1982 Oct;146(4):540-51. Review. No abstract available.

PMID:
6288809
5.

Changing poliovirus vaccine policy can be controversial at best.

Faden H.

Adv Pediatr Infect Dis. 1997;13:305-32. Review. No abstract available.

PMID:
9544317
7.

Polio eradication: the OPV paradox.

Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ.

Rev Med Virol. 2003 Sep-Oct;13(5):277-91. Review.

PMID:
12931339
8.

Role of injectable and oral polio vaccines in polio eradication.

John J.

Expert Rev Vaccines. 2009 Jan;8(1):5-8. doi: 10.1586/14760584.8.1.5. Review. No abstract available.

PMID:
19093765
9.

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.

Cáceres VM, Sutter RW.

Clin Infect Dis. 2001 Aug 15;33(4):531-41. Epub 2001 Jul 9. Review.

PMID:
11462191
10.

Oral polio vaccines and their role in polio eradication in India.

Paul Y.

Expert Rev Vaccines. 2009 Jan;8(1):35-41. doi: 10.1586/14760584.8.1.35. Review.

PMID:
19093771
11.

Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.

Verdijk P, Rots NY, Bakker WA.

Expert Rev Vaccines. 2011 May;10(5):635-44. doi: 10.1586/erv.11.51. Review.

PMID:
21604984
12.

Universal use of inactivated polio vaccine.

Falleiros Carvalho LH, Weckx LY.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S75-82. Epub 2006 Jun 21. Review.

13.

Maxwell Finland lecture: viral vaccines and their ways.

Horstmann DM.

Rev Infect Dis. 1979 May-Jun;1(3):502-16. Review. No abstract available.

PMID:
399363
14.

[End phase challenges of poliomyelitis eradication programme realization].

Jarzabek Z.

Przegl Epidemiol. 2005;59(1):59-68. Review. Polish.

PMID:
16013411
15.

[Universal use of inactivated poliovirus vaccine--the needs and challenges].

Shimizu H, Takeda N.

Nihon Rinsho. 2008 Oct;66(10):1950-5. Review. Japanese.

PMID:
18939495
16.

[How poliomyelitis is to be eradicated completely].

Seĭbil' VB.

Zh Mikrobiol Epidemiol Immunobiol. 2002 Mar-Apr;(2):107-13. Review. Russian.

PMID:
12043142
17.

Vaccines based on recombinant antigen strategies.

Minor P.

Dev Biol (Basel). 2001;105:189-94. Review. No abstract available.

PMID:
11763327
18.

[Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis].

Gendon IuZ.

Vopr Virusol. 1988 Mar-Apr;33(2):137-41. Review. Russian. No abstract available.

PMID:
2457986
19.

Poliovirus biology.

Minor PD.

Structure. 1996 Jul 15;4(7):775-8. Review.

Supplemental Content

Support Center